Eliminate Hepatitis C/EC Partnership Evaluation Protocol

NCT04061551 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-08-24

No results posted yet for this study

Summary

The Eliminate Hepatitis C (EC) Partnership project is a multi-site, multi-year project aiming to enhance and extend hepatitis C virus (HCV) care and treatment among people who inject drugs (PWID) through nurse-led models of care in the community and the prison system. The project will implement and evaluate a health service intervention to enhance HCV response by improving health promotion, offering training and education to service providers, streamlining clinical pathways, utilising data systems and surveillance and implementing the results of ongoing research and evaluation.

Health services data will be used to assess the impact of the EC nurse-led support, to enhance the clinical pathway and increase HCV testing, linkage to care and treatment uptake in community and prison settings. This will include provider and client interviews and a sentinel surveillance system (ACCESS) that will track and monitor impact indicators including HCV testing, linkage to care and treatment uptake at the service and population level.

Overall, evaluation data will be used to monitor the uptake of HCV treatment in PWID, monitor the effectiveness of community- and prison-based treatment program and assess the cost and feasibility of treating \>1160 PWID in community-/prison-based program and assess changes in HCV prevalence in Victoria and modelling the impact of treating PWID to inform HCV elimination models in Australia and globally.

Conditions

  • Hepatitis C
  • Chronic Hepatitis c
  • Hepatitis C, Chronic

Interventions

OTHER

EC clinic support - whole of practice interventions delivery through nurse-led model

The primary interventions will be delivered through a team of nurses, an evaluation team and practice support team that will be working with each of the services to improved Hepatitis C service delivery. The EC project team will predominantly be involved in working with providers and staff at EC sites to implement key interventions that have been collated into a Primary Care Practice Toolkit, which cover three domains; patient support, provider support and practice Support. The toolkit is designed to be an educational and implementation resource that the nursing team will support services to deliver. * Patient support to reduce the impact of hepatitis C and other blood borne viruses * Provider support to reduce the impact of hepatitis C and other blood borne viruses * Practice support to reduce the impact of hepatitis C and other blood borne viruses

Sponsors & Collaborators

  • Burnet Institute

    collaborator OTHER
  • The Alfred

    collaborator OTHER
  • St Vincent's Hospital Melbourne

    collaborator OTHER
  • HepatitisVictoria

    collaborator UNKNOWN
  • Harm Reduction Australia

    collaborator UNKNOWN
  • Victoria State Government

    collaborator UNKNOWN
  • Gilead Sciences

    collaborator INDUSTRY
  • National Health and Medical Research Council, Australia

    collaborator OTHER
  • Macfarlane Burnet Institute for Medical Research and Public Health Ltd

    lead OTHER

Principal Investigators

  • Margaret E Hellard, MD PhD · Burnet Institute and Alfred Health

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04061551 on ClinicalTrials.gov